• PDF: Delivered by email usually within 4 to 8 UK business hours.

Belgium: Pharmaceuticals Industry Guide

  • Publication Date:March 2011
  • Publisher:Datamonitor
  • Product Type: Report
  • Pages:74

Belgium: Pharmaceuticals Industry Guide

Datamonitor's Belgium: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Belgium Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
  • Provides textual analysis of the industry's prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

The Belgian biotechnology market had total revenue of $5.1 billion in 2009, representing a compound annual growth rate (CAGR) of 8.6% for the period spanning 2005-2009.

The Belgian generics market had total revenue of $0.5 billion in 2009, representing a compound annual growth rate (CAGR) of 13.3% for the period spanning 2005-2009.

The Belgian OTC pharmaceuticals market generated total revenues of $975.2 million in 2009, representing a compound annual growth rate (CAGR) of 2.1% for the period spanning 2005-2009.

The Belgian pharmaceuticals market had total revenue of $6.5 billion in 2010, representing a compound annual growth rate (CAGR) of 4.7% for the period spanning 2006-2010.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
  • BIOTECHNOLOGY IN BELGIUM
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Five Forces Analysis
    • Market Forecasts
  • GENERICS IN BELGIUM
    • Market Overview
    • Market Value
    • Market Volume
    • Market Segmentation II
    • Five Forces Analysis
    • Market Forecasts
  • OTC PHARMACEUTICALS IN BELGIUM
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Market Share
    • Five Forces Analysis
    • Market Distribution
    • Market Forecasts
  • PHARMACEUTICALS IN BELGIUM
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Market Share
    • Five Forces Analysis
    • Market Forecasts
  • MACROECONOMIC INDICATORS
  • APPENDIX
    • Data Research Methodology
    • About Datamonitor
    • Disclaimer
  • LIST OF TABLES
    • Table 1: Belgium biotechnology market value: $ billion, 2005-09
    • Table 2: Belgium biotechnology market segmentation I:% share, by value, 2009
    • Table 3: Belgium biotechnology market segmentation II: % share, by value, 2009
    • Table 4: Belgium biotechnology market value forecast: $ billion, 2009-14
    • Table 5: Belgium generics market value: $ million, 2005-09
    • Table 6: Belgium generics market volume: volume penetration, 2005-09
    • Table 7: Belgium generics market segmentation II: % share, by value, 2009
    • Table 8: Belgium generics market value forecast: $ million, 2009-14
    • Table 9: Belgium generics market volume forecast: volume penetration, 2009-14
    • Table 10: Belgium OTC pharmaceuticals market value: $ million, 2005-09
    • Table 11: Belgium OTC pharmaceuticals market segmentation I:% share, by value, 2009
    • Table 12: Belgium OTC pharmaceuticals market segmentation II: % share, by value, 2009
    • Table 13: Belgium OTC pharmaceuticals market share: % share, by value, 2009
    • Table 14: Belgium OTC pharmaceuticals market distribution: % share, by value, 2009
    • Table 15: Belgium OTC pharmaceuticals market value forecast: $ million, 2009-14
    • Table 16: Belgium pharmaceuticals market value: $ billion, 2006-10(e)
    • Table 17: Belgium pharmaceuticals market segmentation I:% share, by value, 2010(e)
    • Table 18: Belgium pharmaceuticals market segmentation II: % share, by value, 2010(e)
    • Table 19: Belgium pharmaceuticals market share: % share, by value, 2010(e)
    • Table 20: Belgium pharmaceuticals market value forecast: $ billion, 2010-15
    • Table 21: Belgium size of population (million), 2006-10
    • Table 22: Belgium GDP (constant 2000 prices, $ billion), 2006-10
    • Table 23: Belgium GDP (current prices, $ billion), 2006-10
    • Table 24: Belgium inflation, 2006-10
    • Table 25: Belgium consumer price index (absolute), 2006-10
    • Table 26: Belgium exchange rate, 2006-10
  • LIST OF FIGURES
    • Figure 1: Belgium biotechnology market value: $ billion, 2005-09
    • Figure 2: Belgium biotechnology market segmentation I:% share, by value, 2009
    • Figure 3: Belgium biotechnology market segmentation II: % share, by value, 2009
    • Figure 4: Forces driving competition in the biotechnology market in Belgium, 2009
    • Figure 5: Drivers of buyer power in the biotechnology market in Belgium, 2009
    • Figure 6: Drivers of supplier power in the biotechnology market in Belgium, 2009
    • Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Belgium, 2009
    • Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Belgium, 2009
    • Figure 9: Drivers of degree of rivalry in the biotechnology market in Belgium, 2009
    • Figure 10: Belgium biotechnology market value forecast: $ billion, 2009-14
    • Figure 11: Belgium generics market value: $ million, 2005-09
    • Figure 12: Belgium generics market volume: volume penetration, 2005-09
    • Figure 13: Belgium generics market segmentation II: % share, by value, 2009
    • Figure 14: Forces driving competition in the generics market in Belgium, 2009
    • Figure 15: Drivers of buyer power in the generics market in Belgium, 2009
    • Figure 16: Drivers of supplier power in the generics market in Belgium, 2009
    • Figure 17: Factors influencing the likelihood of new entrants in the generics market in Belgium, 2009
    • Figure 18: Factors influencing the threat of substitutes in the generics market in Belgium, 2009
    • Figure 19: Drivers of degree of rivalry in the generics market in Belgium, 2009
    • Figure 20: Belgium generics market value forecast: $ million, 2009-14
    • Figure 21: Belgium generics market volume forecast: volume penetration, 2009-14
    • Figure 22: Belgium OTC pharmaceuticals market value: $ million, 2005-09
    • Figure 23: Belgium OTC pharmaceuticals market segmentation I:% share, by value, 2009
    • Figure 24: Belgium OTC pharmaceuticals market segmentation II: % share, by value, 2009
    • Figure 25: Belgium OTC pharmaceuticals market share: % share, by value, 2009
    • Figure 26: Forces driving competition in the OTC pharmaceuticals market in Belgium, 2009
    • Figure 27: Drivers of buyer power in the OTC pharmaceuticals market in Belgium, 2009
    • Figure 28: Drivers of supplier power in the OTC pharmaceuticals market in Belgium, 2009
    • Figure 29: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Belgium, 2009
    • Figure 30: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Belgium, 2009
    • Figure 31: Drivers of degree of rivalry in the OTC pharmaceuticals market in Belgium, 2009
    • Figure 32: Belgium OTC pharmaceuticals market distribution: % share, by value, 2009
    • Figure 33: Belgium OTC pharmaceuticals market value forecast: $ million, 2009-14
    • Figure 34: Belgium pharmaceuticals market value: $ billion, 2006-10(e)
    • Figure 35: Belgium pharmaceuticals market segmentation I:% share, by value, 2010(e)
    • Figure 36: Belgium pharmaceuticals market segmentation II: % share, by value, 2010(e)
    • Figure 37: Belgium pharmaceuticals market share: % share, by value, 2010(e)
    • Figure 38: Forces driving competition in the pharmaceuticals market in Belgium, 2010
    • Figure 39: Drivers of buyer power in the pharmaceuticals market in Belgium, 2010
    • Figure 40: Drivers of supplier power in the pharmaceuticals market in Belgium, 2010
    • Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Belgium, 2010
    • Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Belgium, 2010
    • Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Belgium, 2010
    • Figure 44: Belgium pharmaceuticals market value forecast: $ billion, 2010-15
+44 20 8816 8548

Ask a question about Belgium: Pharmaceuticals Industry Guide

Enter the characters you see in the picture below
Captcha